Clinical Trial for Patients in the United States and Canada
An Investigational Study for Patients With Acute Traumatic Spinal Cord Injury in the Neck
Patients with recent acute traumatic spinal cord injury (SCI) in the neck area who will undergo decompression/stabilization surgery starting within 72 hours of injury may qualify for the SPRING Trial. The investigational therapy, VX-210, is applied to the spinal cord during the initial decompression/stabilization surgery.
Researchers are now evaluating the efficacy and safety of this investigational therapy. Participants who qualify and are enrolled in the trial will be assigned at random to receive VX-210 or a placebo. Participants will not know if they are being given the therapy or the placebo.
Follow-up evaluations are carried out for 12 months after treatment. Researchers will assess the efficacy and safety of VX-210.
For immediate information regarding participation IN this trial, call 617-341-6777
You are now leaving Vertex Spring Trial website.
You are now leaving www.vertexscitrial.com. Vertex Pharmaceuticals Incorporated is not responsible for the content of the site you are about to visit. Please click "OK" to continue or "Cancel" to go back to www.vertexscitrial.com.